(C) Items recommended as the best practice in a routine clinical setting (C indicates “Clinical recommendation”).(R) Items recommended when FFPE samples are used for the comprehensive genomic analysis (including whole‐exome and whole‐transcriptome sequencing) in the interventional study or as genomic testing not covered by the national health insurance system in Japan (R means “Research recommendation”).(N) Items that should be avoided (N indicates “Not recommended”)